Matarin Capital Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-78,279
| Closed | -$1.01M | – | 292 |
|
|
2019
Q1 | $1.01M | Buy |
78,279
+16,417
| +27% | +$211K | 0.07% | 208 |
|
|
2018
Q4 | $940K | Buy |
61,862
+484
| +0.8% | +$7.35K | 0.08% | 204 |
|
|
2018
Q3 | $1.23M | Sell |
61,378
-1,194
| -2% | -$23.9K | 0.08% | 205 |
|
|
2018
Q2 | $1.22M | Buy |
+62,572
| New | +$1.22M | 0.09% | 199 |
|
|
2017
Q4 | – | Sell |
-36,108
| Closed | -$666K | – | 326 |
|
|
2017
Q3 | $666K | Sell |
36,108
-339
| -0.9% | -$6.26K | 0.06% | 223 |
|
|
2017
Q2 | $671K | Buy |
36,447
+2,034
| +6% | +$37.4K | 0.06% | 203 |
|
|
2017
Q1 | $776K | Buy |
34,413
+17,951
| +109% | +$405K | 0.08% | 205 |
|
|
2016
Q4 | $573K | Buy |
+16,462
| New | +$573K | 0.06% | 197 |
|